Spago Nanomedical AB (publ)
F:7UX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Spago Nanomedical AB (publ)
F:7UX
|
SE |
|
Komax Holding AG
F:KR8
|
CH |
|
V
|
Vizsla Copper Corp
F:97E0
|
CA |
|
P
|
Patrick Industries Inc
F:PK2
|
US |
|
algoWatt SpA
F:TI5
|
IT |
|
Meyer Burger Technology AG
OTC:MYBUF
|
CH |
|
D
|
Deutsche Pfandbriefbank AG
DUS:PBB
|
DE |
|
Articore Group Ltd
F:WAB0
|
AU |
|
Nykode Therapeutics ASA
F:5VB
|
NO |
|
S
|
Sumitomo Metal Mining Co Ltd
SWB:S19
|
JP |
|
TME Pharma NV
F:0N6A
|
DE |
|
Focus Financial Partners Inc
F:2JE
|
US |
|
First Savings Financial Group Inc
F:8N4
|
US |
|
L
|
Lucas Bols Amsterdam BV
F:LUA
|
NL |
|
Mayfair Gold Corp
OTC:MFGCD
|
CA |
|
Flexsteel Industries Inc
F:FX3
|
US |
|
ICICI Securities Ltd
BSE:541179
|
IN |
Bankruptcy Probability
Spago Nanomedical AB (publ)'s probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Spago Nanomedical AB (publ) Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SE |
S
|
Spago Nanomedical AB (publ)
STO:SPAGO
|
91.4m SEK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
462.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
233.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
178B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
136.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
85.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
56.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
80.6B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Spago Nanomedical AB (publ)'s probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Spago Nanomedical AB (publ) has no debt.
You can find a full breakdown on its Balance Sheet.
